| William D Zeichner, MD | |
|
6701 N Charles St, Towson, MD 21204-6808 | |
| (512) 574-5552 | |
| Not Available |
| Full Name | William D Zeichner |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 7 Years |
| Location | 6701 N Charles St, Towson, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043751472 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D0091240 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greater Baltimore Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gbmc Hospital Based Services Llc | 6002299369 | 49 |
News Archive
Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.
Most of modern medicine has physical tests or objective techniques to define much of what ails us. Yet, there is currently no blood or genetic test, or impartial procedure that can definitively diagnose a mental illness, and certainly none to distinguish between different psychiatric disorders with similar symptoms.
An emerging body of research suggests that Alzheimer's disease may be linked to insulin resistance, constituting a third type of diabetes. This model is based on several observations including an increased risk of developing Alzheimer's disease for diabetic patients, and reduced insulin levels in the brain tissue of Alzheimer's disease patients. Though intriguing, the existing evidence does not reveal if defective insulin signaling is causative of Alzheimer's or how insulin resistance impacts cognitive function.
Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archives journals.
Using a sophisticated, custom-designed 3D printer, regenerative medicine scientists at Wake Forest Baptist Medical Center have proved that it is feasible to print living tissue structures to replace injured or diseased tissue in patients.
› Verified 1 days ago
| Entity Name | Anesthesia Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871548156 PECOS PAC ID: 4587559026 Enrollment ID: O20040216000401 |
News Archive
Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.
Most of modern medicine has physical tests or objective techniques to define much of what ails us. Yet, there is currently no blood or genetic test, or impartial procedure that can definitively diagnose a mental illness, and certainly none to distinguish between different psychiatric disorders with similar symptoms.
An emerging body of research suggests that Alzheimer's disease may be linked to insulin resistance, constituting a third type of diabetes. This model is based on several observations including an increased risk of developing Alzheimer's disease for diabetic patients, and reduced insulin levels in the brain tissue of Alzheimer's disease patients. Though intriguing, the existing evidence does not reveal if defective insulin signaling is causative of Alzheimer's or how insulin resistance impacts cognitive function.
Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archives journals.
Using a sophisticated, custom-designed 3D printer, regenerative medicine scientists at Wake Forest Baptist Medical Center have proved that it is feasible to print living tissue structures to replace injured or diseased tissue in patients.
› Verified 1 days ago
| Entity Name | North American Partners In Anesthesia Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093707879 PECOS PAC ID: 1850283144 Enrollment ID: O20040330000405 |
News Archive
Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.
Most of modern medicine has physical tests or objective techniques to define much of what ails us. Yet, there is currently no blood or genetic test, or impartial procedure that can definitively diagnose a mental illness, and certainly none to distinguish between different psychiatric disorders with similar symptoms.
An emerging body of research suggests that Alzheimer's disease may be linked to insulin resistance, constituting a third type of diabetes. This model is based on several observations including an increased risk of developing Alzheimer's disease for diabetic patients, and reduced insulin levels in the brain tissue of Alzheimer's disease patients. Though intriguing, the existing evidence does not reveal if defective insulin signaling is causative of Alzheimer's or how insulin resistance impacts cognitive function.
Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archives journals.
Using a sophisticated, custom-designed 3D printer, regenerative medicine scientists at Wake Forest Baptist Medical Center have proved that it is feasible to print living tissue structures to replace injured or diseased tissue in patients.
› Verified 1 days ago
| Entity Name | Gbmc Hospital Based Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730824400 PECOS PAC ID: 6002299369 Enrollment ID: O20220818002500 |
News Archive
Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.
Most of modern medicine has physical tests or objective techniques to define much of what ails us. Yet, there is currently no blood or genetic test, or impartial procedure that can definitively diagnose a mental illness, and certainly none to distinguish between different psychiatric disorders with similar symptoms.
An emerging body of research suggests that Alzheimer's disease may be linked to insulin resistance, constituting a third type of diabetes. This model is based on several observations including an increased risk of developing Alzheimer's disease for diabetic patients, and reduced insulin levels in the brain tissue of Alzheimer's disease patients. Though intriguing, the existing evidence does not reveal if defective insulin signaling is causative of Alzheimer's or how insulin resistance impacts cognitive function.
Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archives journals.
Using a sophisticated, custom-designed 3D printer, regenerative medicine scientists at Wake Forest Baptist Medical Center have proved that it is feasible to print living tissue structures to replace injured or diseased tissue in patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William D Zeichner, MD 6701 N Charles St, Towson, MD 21204-6881 Ph: (512) 574-5552 | William D Zeichner, MD 6701 N Charles St, Towson, MD 21204-6808 Ph: (512) 574-5552 |
News Archive
Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.
Most of modern medicine has physical tests or objective techniques to define much of what ails us. Yet, there is currently no blood or genetic test, or impartial procedure that can definitively diagnose a mental illness, and certainly none to distinguish between different psychiatric disorders with similar symptoms.
An emerging body of research suggests that Alzheimer's disease may be linked to insulin resistance, constituting a third type of diabetes. This model is based on several observations including an increased risk of developing Alzheimer's disease for diabetic patients, and reduced insulin levels in the brain tissue of Alzheimer's disease patients. Though intriguing, the existing evidence does not reveal if defective insulin signaling is causative of Alzheimer's or how insulin resistance impacts cognitive function.
Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archives journals.
Using a sophisticated, custom-designed 3D printer, regenerative medicine scientists at Wake Forest Baptist Medical Center have proved that it is feasible to print living tissue structures to replace injured or diseased tissue in patients.
› Verified 1 days ago
Dr. Lewis Hogge, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
Deondra Patrice-simmons Asike, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St # 4226, Towson, MD 21204 Phone: 410-296-4616 | |
Aloise Diedrich, Anesthesiology Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 443-849-2000 | |
Dr. John Yang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
Dr. Gary Michael Vita, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7505 Osler Dr, Towson, MD 21204 Phone: 410-337-5337 | |
Theodore Grabow, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8322 Bellona Ave, Suite 330, Towson, MD 21204 Phone: 410-825-6945 Fax: 410-825-8974 |